Public health

#Data #Healthcare #Public health #Report #Study

Research reveals attitudes to Covid-19 treatment in the UK 

Pharmaceutical companies must keep improving Covid-19 treatments in line with new variants without sidelining work in other areas of health, according to new data from YouGov and Informa Pharma Intelligence, a provider for the biopharma industry.   The report  This data, included in Informa Pharma’s ‘Q4… Read More

#Covid-19 #News

#Covid-19 #Healthcare #Immunology / Virology & Vaccines #Public health

European Commission authorises Novavax Covid-19 vaccine

Novavax has been granted conditional marketing authorisation by the European Commission (EC) for Nuvaxovid Covid-19 vaccine.  Context  The vaccine is for active immunisation to prevent Covid-19 caused by SARS-CoV-2 in individuals 18 years of age and older and the authorisation follows the European Medicines Agency’s (EMA) Committee for Medicinal… Read More

#Covid-19 #News #Trending News

#Covid-19 #Healthcare #Immunology / Virology & Vaccines #Public health #Research

NIH scientists urge pursuit of universal coronavirus vaccine 

Physician-scientists of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), have published a paper in The New England Journal of Medicine which suggests that in order to counter future coronavirus outbreaks, the global scientific and medical research community should focus… Read More

#News #Trending News

#Covid variants #Covid-19 #Public health

PerkinElmer launches kit to strengthen SARS-CoV-2 surveillance 

PerkinElmer has announced the research use only (RUO) launch of the NEXTFLEX Variant-Seq SARS-CoV-2 Kit v2 to accelerate the detection of SARS-CoV-2 variants, which will allow laboratories to increase sequencing throughput and make reliable variant identifications.  What is NEXTFLEX?   Using positive SARS-CoV-2 samples, the NEXTFLEX… Read More

#Covid-19 #News #Trending News

#Contraception #Healthcare #Public health

The first transdermal contraceptive patch licensed in the UK  

Gedeon Richter has become marketing authorisation holder for Evra, a once-weekly contraception for women of fertile age, which they say is the first and only transdermal contraceptive patch licenced in the UK.   Tamas Neubauer, Managing Director of UK and Ireland at Gedeon Richter, believes that the addition of a patch to their… Read More

#News #Trending News

#Healthcare #Public health #Rare disease

Rare disease centre to accelerate biotech growth 

Emmes has launched a rare disease centre, Orphan Reach, to combine its health research across the public sector and biopharmaceutical industry, with Orphan Reach, a UK-based CRO, acquired by Emmes in May 2021.  The expanded Orphan Reach is dedicated to the advancement of rare disease research by providing specialised clinical… Read More

#News

#Drug development #Funding #Health #Healthcare #Public health

UK budget plans: healthcare industry reaction 

In the Autumn 2021 budget delivered by UK Chancellor of the Exchequer, Rishi Sunak, on 27 October, the Government announced a range of measures designed to benefit UK science, business, and technology. This, at a time where the UK’s health service will need to tackle backlogs through the Winter… Read More

#News #Trending News

#Cancer research #Pharmaceuticals #Public health

UK: Research and clinical trials should be at the heart of NHS recovery 

NHS England and public sector bodies must restart clinical trials as part of the process to improve cancer services the pharmaceutical industry has warned.   David Watson, Executive Director for Patient Access at the Association of the British Pharmaceutical Industry, gave evidence to the Health and Social Care Committee for its inquiry… Read More

#News

#Collaboration #Digital focus #Life sciences #Public health

Pistoia Alliance responds to the needs of the life science industry 

The Pistoia Alliance has announced plans to respond to the changing needs of the life science industry as digital transformation accelerates.  The Alliance has hired Imran Haq, Anca Ciobanu and Linda Kasim to lead the three new themes of its reorganised project portfolio: Emerging Science and Technology,… Read More

#News

#AI #Biopharmaceuticals #ELRIG #Public health

Shifting the biopharmaceutical landscape with AI 

Valo Health is a technology company built to transform drug discovery and development using human-centric data and artificial intelligence-powered compute. VP of Integrated Research, Guido Lanza talks to DDW in its Drug Discovery 2021 supplement about how Valo Health is re-inventing and innovating to overcome the fragmented, outdated drug discovery and development… Read More

#Editor's Choice #Exclusive Content #News #Opinion

#Clinical trials #ELRIG #Healthcare #Public health

An inside perspective on the value of diversity in health research 

In DDW and ELRIG UK's Drug Discovery 2021 supplement, CEO and Founder of Egality Health, Annette Crosse, offers insight into the importance of diversity in clinical trials and of overcoming limitations in healthcare research to re-imagine a system which provides safe, effective and innovative therapies for the entire population.  Annette Crosse describes… Read More

#Editor's Choice #Exclusive Content #News

#Biologics / Biotechnology #Biotechnology #Covid-19 #Life sciences #Public health

Europe’s emerging biotechs: Challenges, opportunities and funding

Listen to this article on the DDW Podcast: John Macdonald is Vice President, Venture & Financial Alliances at ICON. He examines the European biotech sector – its expertise and opportunities and potential for growth. By harnessing biological processes on a cellular and biomolecular level, biotech is benefitting industries as varied as… Read More

#Business & Investment #Covid-19 #Editor's Choice #Exclusive Content #Market Reports #News #Opinion

#Covid-19 #Investment #Life sciences #Public health #Social enterprise

Mologic becomes a ‘social enterprise’ following acquisition

A group of philanthropic funds and investors led by the Soros Economic Development Fund (SEDF), with support from the Bill & Melinda Gates Foundation, has launched Global Access Health (GAH), a social enterprise that aims to expand access to affordable medical technology. The group has financed the acquisition of Mologic,… Read More

#News

#AI / data analytics / healthtech / informatics #Genomics #Public health

AWS for Health: accelerating innovation through data access

Dotmatics has announced its support of the AWS for Health initiative from Amazon Web Services (AWS), which aims to improve laboratory efficiency and accelerate the pace of scientific innovation by facilitating more rapid data access, analysis and exchange between scientists worldwide. AWS for Health is an initiative featuring services and… Read More

#News

#Biosciences #Healthcare #Pharma #Public health

Comment: investors ‘won’t appreciate the overhang’ following GSK spin-off

At an update to investors, GlaxoSmithKline (GSK) provided details of its strategy, outlook for growth and plans to create shareholder value, following the planned demerger in mid-2022 of its Consumer Healthcare business. An equity research expert suggests that while targets are friendly, investors will not get a completely clean… Read More

#News

#Covid-19 #Immunology / Virology & Vaccines #Public health #Sinovac #Vaccines

Has China approved a Covid-19 vaccine for three year olds?

The New York Times has reported that the Chairman of the Chinese drug maker Sinovac said China had approved the company’s Covid-19 vaccine for children as young as three, which the media outlet explains would make the country the first in the world to endorse a vaccine for children of… Read More

#Covid-19 #News #Trending News